<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-141285" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Noninvasive Ventilation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gong</surname>
            <given-names>Yiran</given-names>
          </name>
          <aff>Wayne State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sankari</surname>
            <given-names>Abdulghani</given-names>
          </name>
          <aff>Wayne State University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yiran Gong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abdulghani Sankari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-141285.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Non-invasive positive pressure ventilation involves the delivery of oxygen into the lungs via positive pressure without the need for endotracheal intubation. It is used in acute and chronic respiratory failure but requires careful monitoring and titration to ensure its success and avoid complications. This activity reviews the physiology behind non-invasive positive pressure ventilation, its indications, contraindications, preparation, and techniques. It highlights the interprofessional team's role and importance during the procedure's initiation and maintenance.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess&#x000a0;the physiology of non-invasive positive pressure ventilation.</p></list-item><list-item><p>Identify the indications and contraindications of non-invasive positive pressure ventilation.</p></list-item><list-item><p>Evaluate&#x000a0;the technique for initiation and monitoring of non-invasive positive pressure ventilation.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=141285&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=141285">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-141285.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Non-invasive ventilation (NIV) was first reported in the mid-eighteenth century by a Scottish physician, John Dalziel.<xref ref-type="bibr" rid="article-141285.r1">[1]</xref> In 1864, Alfred F. Jones patented the first American tank respirator in the iron lung, known as non-invasive negative pressure ventilation. In 1938, Barach et al described a new form of NIV as a treatment for pulmonary edema.<xref ref-type="bibr" rid="article-141285.r2">[2]</xref> However, Oertel described intermittent positive pressure (NPPV) earlier by Oertel (1878).<xref ref-type="bibr" rid="article-141285.r3">[3]</xref>&#x000a0;During the polio epidemic and due to very high mortality (more than 80%), innovation was sparked by physicians such as&#x000a0;Bjorn Ibsen, an anesthesiologist from&#x000a0;Copenhagen, Denmark, who applied positive pressure ventilation&#x000a0;in 1952 via trach but required manual delivery.&#x000a0;The approach dropped the mortality by more than half (to nearly 40%); however, the pressure delivery was a&#x000a0;logistical problem, as there were no positive pressure ventilators, and&#x000a0;patients needed to be&#x000a0;bagged by hand.<xref ref-type="bibr" rid="article-141285.r4">[4]</xref>&#x000a0;Over the past century, positive pressure ventilation (NPPV) has dramatically improved and is used to treat respiratory failure from multiple etiologies. It has been proven effective in preventing intubation compared to standard oxygen therapy in the acute setting. NPPV encompasses several methods of respiratory support, the most common being Bilevel Positive Airway Pressure (BPAP). The latest American Thoracic Society/European Respiratory Journal guidelines support the use of NPPV in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and acute respiratory failure secondary to cardiogenic pulmonary edema, where evidence and level of recommendation are the strongest.<xref ref-type="bibr" rid="article-141285.r5">[5]</xref>&#x000a0;However, there is a body of evidence and conditional recommendations that NPPV is effective in other settings of acute respiratory failure, such as post-operative and chest trauma. In addition, several studies support the use of NPPV in various chronic respiratory diseases.<xref ref-type="bibr" rid="article-141285.r6">[6]</xref><xref ref-type="bibr" rid="article-141285.r7">[7]</xref></p>
      </sec>
      <sec id="article-141285.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Lung compliance refers to the change in volume that accompanies a change in pressure in the lung. Compliance is calculated according to the formula dV/dP, where V refers to the volume of the lung and P refers to the transpulmonary pressure (TPP), which can be otherwise expressed as alveolar pressure (Palv) &#x02013; intrapleural pressure (Ppl). TPP can be thought of as the pressure that prevents the inward recoil of the lung, or rather, the pressure that keeps the lung from collapsing on itself.<xref ref-type="bibr" rid="article-141285.r8">[8]</xref>&#x000a0;At rest, TPP is slightly positive, and during inspiration, as the diaphragm contracts, Ppl decrease, causing TPP to increase and, subsequently, the lung to expand. Normal lung tissue is based on a compliance curve in which a change in TPP generates a maximum increase in lung volume. Lung diseases can either cause an increase or decrease in the&#x000a0;lung's compliance&#x000a0;and distortion of the curve, resulting in an increased TPP to generate the appropriate change in lung volume. For example, emphysema causes the compliance curve to be displaced upwards, resulting in the TPP being in a region where increased TPP&#x000a0;results in a minimal increase in lung volume.<xref ref-type="bibr" rid="article-141285.r9">[9]</xref>&#x000a0;In contrast, acute respiratory distress syndrome and cardiogenic pulmonary edema cause an overall decrease in compliance due to liquid-filled alveoli exerting mechanical stress on air-filled alveoli.<xref ref-type="bibr" rid="article-141285.r10">[10]</xref>&#x000a0;NPPV reduces the work of breathing through&#x000a0;3 different methods. By applying positive end-expiratory pressure (PEEP) through expiratory positive airway pressure (EPAP), NPPV allows the body to overcome the dynamic intrinsic positive end-expiratory pressure threshold required to initiate a breath and increase lung compliance.<xref ref-type="bibr" rid="article-141285.r11">[11]</xref>&#x000a0;By applying inspiratory positive airway pressure (IPAP), NPPV contributes a more significant portion of the TPP required during inspiration, thus reducing the body's breathing work.<xref ref-type="bibr" rid="article-141285.r12">[12]</xref></p>
      </sec>
      <sec id="article-141285.s4" sec-type="Indications">
        <title>Indications</title>
        <p>According to the latest ATS/ERJ guidelines from 2020 for acute respiratory failure, NPPV carries a strong recommendation for the following in the setting of acute respiratory failure (ARF):</p>
        <list list-type="bullet">
          <list-item>
            <p>BPAP for acute or acute-on-chronic respiratory acidosis secondary to COPD exacerbation where pH&#x000a0;&#x0003c;/= 7.35</p>
          </list-item>
          <list-item>
            <p>BPAP&#x000a0;is the prevention of endotracheal intubation and mechanical ventilation in a patient that is not immediately deteriorating</p>
          </list-item>
          <list-item>
            <p>BPAP or continuous positive airway pressure (CPAP) for cardiogenic pulmonary edema<xref ref-type="bibr" rid="article-141285.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>ATS/ERJ guidelines carry a conditional recommendation for the following in the setting of ARF:</p>
        <list list-type="bullet">
          <list-item>
            <p>Early NIV for immunocompromised patients with ARF</p>
          </list-item>
          <list-item>
            <p>Post-operative ARF</p>
          </list-item>
          <list-item>
            <p>As palliation to&#x000a0;dyspneic patients in the setting of terminal cancer or other terminal conditions</p>
          </list-item>
          <list-item>
            <p>Chest trauma patients with ARF</p>
          </list-item>
          <list-item>
            <p>Prevention of post-extubation respiratory failure in high-risk patients</p>
          </list-item>
        </list>
        <p>In addition, NPPV has been effective in treating&#x000a0;various chronic respiratory diseases. These diseases include chronic stable COPD with hypercapnia, obesity hypoventilation syndrome, obstructive sleep apnea, respiratory failure secondary to neuromuscular disease, and restrictive thoracic disorders.<xref ref-type="bibr" rid="article-141285.r6">[6]</xref><xref ref-type="bibr" rid="article-141285.r7">[7]</xref></p>
      </sec>
      <sec id="article-141285.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>
<bold>Absolute Contraindications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Facial trauma/burns</p>
          </list-item>
          <list-item>
            <p>Fixed upper airway obstruction</p>
          </list-item>
          <list-item>
            <p>Active vomiting</p>
          </list-item>
          <list-item>
            <p>Respiratory or cardiac arrest<xref ref-type="bibr" rid="article-141285.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Relative Contraindications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>A recent facial, upper airway, or upper GI tract surgery</p>
          </list-item>
          <list-item>
            <p>Inability to protect the airway</p>
          </list-item>
          <list-item>
            <p>Life-threatening hypoxemia</p>
          </list-item>
          <list-item>
            <p>Medical or hemodynamic instability (hypotensive shock, myocardial infarction requiring intervention, uncontrolled ischemia or arrhythmias)</p>
          </list-item>
          <list-item>
            <p>Altered mental status/agitation</p>
          </list-item>
          <list-item>
            <p>Bowel obstruction</p>
          </list-item>
          <list-item>
            <p>Copious respiratory secretions</p>
          </list-item>
          <list-item>
            <p>Focal consolidation</p>
          </list-item>
          <list-item>
            <p>Undrained pneumothorax</p>
          </list-item>
          <list-item>
            <p>Severe co-morbidity</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-141285.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>
<bold>NPPV Circuit Components</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>NIV device:&#x000a0;While CPAP is delivered using a continuous flow, BPAP is typically produced using&#x000a0;2 modes: Spontaneous or spontaneous/timed (S/T). Spontaneous mode is where the machine augments the patient's spontaneous breaths, whereas S/T mode includes a backup rate slightly below the patient's respiratory rate. Newer versions of NPPV devices were developed to add more monitoring features and ventilatory assistance, such as averaged volume-assured pressure support (AVAPS). The AVAPS device delivers a constant tidal pressure-volume to patients and uses a specific algorithm that automatically calculates the pressure changes needed to maintain an optimal tidal volume. In addition, AVAPS can be combined with auto&#x02013;expiratory positive airway pressure (AVAPS-AE) to maintain a patient's upper airway patency.<xref ref-type="bibr" rid="article-141285.r14">[14]</xref></p>
            <p>BPAP S/T mode vs. AVAPS</p>
          </list-item>
        </list>
        <table-wrap id="article-141285.table0" position="float" orientation="portrait">
          <table style="height: 350px;" border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td style="width: 184.479px;" rowspan="1" colspan="1">
<bold>BPAP S/T mode</bold>
</td>
                <td style="width: 213.521px;" rowspan="1" colspan="1">
<bold>AVAPS</bold>
</td>
              </tr>
              <tr>
                <td style="width: 184.479px;" rowspan="1" colspan="1">
<p>Fixed IPAP</p>
</td>
                <td style="width: 213.521px;" rowspan="1" colspan="1">Minimum and maximum pressure</td>
              </tr>
              <tr>
                <td style="width: 184.479px;" rowspan="1" colspan="1">Fixed EPAP</td>
                <td style="width: 213.521px;" rowspan="1" colspan="1">EPAP (Auto AE)</td>
              </tr>
              <tr>
                <td style="width: 184.479px;" rowspan="1" colspan="1">
<p>Fixed pressure support (PS):</p>
<p>IPAP-EPAP</p>
</td>
                <td style="width: 213.521px;" rowspan="1" colspan="1">Auto PS</td>
              </tr>
              <tr>
                <td style="width: 184.479px;" rowspan="1" colspan="1">S/T backup rate</td>
                <td style="width: 213.521px;" rowspan="1" colspan="1">Assured average volume</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <list list-type="bullet">
          <list-item>
            <p>Mask: several types of masks exist, including nose masks, nose-mouth masks, and helmets, each with its own set of advantages and disadvantages<xref ref-type="bibr" rid="article-141285.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Tubing</p>
          </list-item>
          <list-item>
            <p>Oxygen supply</p>
          </list-item>
          <list-item>
            <p>Power supply</p>
          </list-item>
          <list-item>
            <p>Humidifier</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-141285.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>NPPV initiation and titration should be performed by experienced physicians who are trained in its use and monitoring. Qualified physicians typically come from internal medicine, anesthesiology, surgery, emergency medicine, pulmonary medicine, and critical care. Support staff for the procedure includes personnel proficient with the device and complications, and this typically comprises respiratory therapists or registered nurses with an essential care background.</p>
      </sec>
      <sec id="article-141285.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>The initiation of NPPV must occur after careful patient, ventilator, and interface selection. As successful NPPV implementation mainly depends on patient cooperation, the goals, process, and complications of this procedure must be explained to the patient in detail before initiation. Following this, mask fitting is started, and the patient should be given time to acclimate to the mask before securing it. The ventilator is then connected to the mask and turned on with oxygen supplementation.&#x000a0;Initiation and titration of NPPV must be performed carefully, closely monitored by the clinician, and with nursing and respiratory therapy. Titration protocols often differ by institution and pathology. In addition, few titration protocols have been published in the literature. One such protocol for NPPV titration for OSA has been published in the Journal of Clinical Sleep Medicine.<xref ref-type="bibr" rid="article-141285.r16">[16]</xref>&#x000a0;In addition, a recently published review in Annals of ATS details a titration protocol for chronic hypercapnic respiratory failure in COPD.<xref ref-type="bibr" rid="article-141285.r17">[17]</xref></p>
        <p>
<bold>Titration of NPPV in an Acute Setting</bold>
</p>
        <p>Clinician&#x000a0;experience&#x000a0;shows that the titration of NPPV in the acute setting in the intensive care unit can be divided into&#x000a0;3 categories. The first category is for patients with simple airway conditions,&#x000a0;such as&#x000a0;obstructive sleep apnea, needing end-expiratory positive airway pressure, or CPAP alone. The titration of pressure in this situation requires overcoming the collapsing pressure of the upper airway, which can be estimated from the actual body weight. From our experience, using 10% of the patient's actual body weight in kilograms would be the starting point of the EPAP or CPAP.</p>
        <p>The second category is for those with hypercapnic or mixed respiratory failures, such as those with acute exacerbation of COPD and no upper airway obstruction (no obesity or suspicion of OSA). In this category of hypercapnic patients,&#x000a0;clinicians can use EPAP of 5 cmH<sub>2</sub>O and add high-intensity pressure support of 10&#x000a0;to 15 cmH<sub>2</sub>O,&#x000a0;which can be titrated based on response in reducing CO<sub>2</sub> (measured by arterial blood gas). A third category is when patients hospitalized with hypercapnic respiratory failure are associated with obesity or obstructive sleep apnea. This group of patients is the most challenging as they require careful adjustment for both inspiratory and expiratory pressures to prevent upper airway collapse while maintaining adequate ventilation. Therefore, in this group of patients,&#x000a0;one must combine the strategy used in the previous&#x000a0;2 categories of patients, where&#x000a0;clinicians can apply sufficient EPAP to overcome the collapsing upper airway pressure using the 10% rule of actual body weight (in kilograms) and add high-intensity pressure support between 10 to 15 cmH<sub>2</sub>O to provide adequate ventilation and titrate based on arterial blood gas.</p>
        <p>Once pH is normalized, the pressure support can be weaned off slowly to allow a slight decrease in hypercapnia that can be managed in an outpatient setting. Patients with chronic respiratory failure suspected of having OHS should be discharged on NPPV until they undergo outpatient diagnostic polysomnography and laboratory PAP titration.&#x000a0;In the meantime, the BPAP S/T mode can be used with empiric settings or auto-titrating NPPV such as VAPS with the auto-expiratory positive airway pressure (VAPS-AE), which can automatically adjust the EPAP to ensure adequate upper airway patency due to OSA. When monitoring to ensure adequate response to NPPV in the acute setting, the clinician must consider the subjective and physiologic responses of the patient. Clinicians should use caution when asking patients about their respiratory status, as some patients minimize or deny discomfort, thus confounding the clinical picture. Patients likely to succeed on NPPV in the acute setting have a drop in their respiratory rate after 1&#x000a0;to 2 hours, a decrease in heart rate, and better ventilator synchrony.<xref ref-type="bibr" rid="article-141285.r18">[18]</xref>&#x000a0; A blood gas should be drawn&#x000a0;1 hour after initiation of BPAP as a decrease in PCO<sub>2</sub> and an increase in pH predict NPPV success. In addition to the parameters above, tidal volume and air leak must be closely monitored as these can contribute to treatment failure if not corrected. The patient's hemodynamics, including blood pressure and heart rate, must be monitored during treatment as intrathoracic pressure right ventricular afterload increases and right ventricular preload decreases. This is consistent with prior studies demonstrating reduced cardiac output after initiating NPPV.<xref ref-type="bibr" rid="article-141285.r19">[19]</xref><xref ref-type="bibr" rid="article-141285.r20">[20]</xref></p>
        <p>
<bold>Titration of NPPV in a Chronic Setting</bold>
</p>
        <p>1) COPD with chronic hypercapnic respiratory failure: NIV is used for patients with COPD and stable hypercapnia (CO<sub>2</sub> &#x02265;52 mmHg). Prospective randomized controlled trials have significantly improved survival and clinical outcomes (less exacerbation rate and better disease control).<xref ref-type="bibr" rid="article-141285.r21">[21]</xref><xref ref-type="bibr" rid="article-141285.r22">[22]</xref>&#x000a0;Contrary to previous studies, the clinical benefits of NIV in stable COPD seem to be due to high-intensity pressure support that targets the normalization of CO<sub>2</sub> (or at least a 20% decrease in CO<sub>2</sub> level).<xref ref-type="bibr" rid="article-141285.r23">[23]</xref>&#x000a0;Clinician experience in stable patients with COPD and chronic hypercapnic respiratory failure&#x000a0;with no evidence of obstructive sleep apnea or obesity indicates using BPAP S/T mode with IPAP 15-20 cmH<sub>2</sub>O. However, when there is obstructive sleep apnea suspicion or obesity (OSA/COPD overlap), EPAP level needs to be adjusted based on their opening pressure (from the PAP titration sleep study when obstructive apnea is eliminated), or if not available, pressure is set empirically based on actual body weight using the above 10% rules (e.g., for a patient whose weight is 70 kg, the EPAP&#x000a0;is set at&#x000a0;7 cmH<sub>2</sub>O).&#x000a0;</p>
        <p>2) Obesity hypoventilation syndrome: OHS is defined as a combination of obesity (body mass index &#x0003e;/=30 kg&#x000b7;m<sup>-2</sup>), daytime hypercapnia (arterial CO<sub>2</sub> &#x0003e;/= 45 mmHg), and diagnosis of OSA (apnea-hypopnea index &#x02265;&#x000a0;5 events/hour) after excluding other causes&#x000a0;of alveolar hypoventilation. OHS and coexistent OSA treatment is CPAP; however, when CPAP is not tolerated or fails to correct ventilation (CO<sub>2</sub> &#x0003e;/= 45mmHg), NPPV (BPAP S/T mode or VAPS) is recommended (see prescription parameters below).<xref ref-type="bibr" rid="article-141285.r24">[24]</xref>&#x000a0;The pressure selection in OHS associated with OSA requires eliminating apnea and hypopnea (AHI &#x0003c;5 event/hour) and fixing the hypoventilation and sustained hypoxia. Therefore, a dedicated pressure titration in the sleep laboratory is recommended&#x000a0;with follow-up in the clinic to measure ABG and adherence to device treatment (usually within 4&#x000a0;to 6 weeks).</p>
        <p>3) Thoracic restrictive disorder (TRD) with hypercapnic respiratory failure: TRD is defined as ventilatory defects associated with elevated CO<sub>2</sub> (&#x02265;45 mmHg) due to neuromuscular disorders (amyotrophic lateral sclerosis, spinal cord injury, muscular dystrophy, diaphragm paralysis, spina bifida, and congenital central hypoventilation syndrome), chest wall deformity, and other ventilatory drive defects without evidence of interstitial lung disease.&#x000a0;The use of NPPV treatment in TRD is similar to other hypoventilation syndromes. It requires careful assessment of OSA and monitoring of CO<sub>2</sub> and oxygenation while the patient is awake&#x000a0;and sleeping after initiation of therapy. BPAP S/T or VAPS should be considered without sleep testing in this condition.</p>
        <table-wrap id="article-141285.table1" position="float" orientation="portrait">
          <table border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p>The prescribing physician determines settings.</p>
<p>Settings: Primary Mode:</p>
<p>AVAPS-AE with Target Tidal Volume</p>
<p>VT (Tidal Volume- 8ml/kg): _____</p>
<p>Max Pressure: _____</p>
<p>PS Max (pressure support max): _____</p>
<p>PS Min (pressure support minimum): _____</p>
<p>EPAP Max: _____</p>
<p>EPAP Min: _____</p>
<p>Rate (if rate= &#x0201c;auto&#x0201d; then &#x0201c;N/A&#x0201d;): ____</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-141285.s9" sec-type="Complications">
        <title>Complications</title>
        <p>The most common complication of NPPV is mask discomfort. More serious adverse effects include skin rash secondary to hypersensitivity or infection and rarely nasal bridge ulcers. Aerophagia and sialorrhea are also complications that may arise. Patients may experience symptoms related to the pressure, including discomfort, ear and sinus pain, or gastric insufflation. Serious side effects from pressure include pneumothorax, pneumocephalus, and, more recently, pneumomediastinum from NPPV in the setting of SARS-CoV-2 pneumonia.<xref ref-type="bibr" rid="article-141285.r25">[25]</xref><xref ref-type="bibr" rid="article-141285.r26">[26]</xref>&#x000a0;Aspiration is a serious complication of NPPV, and steps should be taken during patient selection to ensure that patients on NPPV are at low risk of aspiration. Sedation in NPPV has not been well studied due to the thought process that it can lead to an increased risk of aspiration and hypoventilation.&#x000a0;Rarely, when patients co-present with respiratory failure and compromised cardiac output, NPPV causes hemodynamic compromise due to increased intrathoracic pressure, right ventricular afterload, and reduced preload.&#x000a0;</p>
        <p>The final complication arises from patient-ventilator dyssynchrony with BPAP. This falls under&#x000a0;2 categories: Failure to trigger and cycle, leading to inadequate gas exchange and unnecessary expiratory muscle use. An example of failure to cycle would be during COPD, where rapid inhalations may not give the BPAP adequate time to cycle from inspiration to expiration. Thus, the patient is expiring against the ventilator&#x02019;s effort to deliver inspiratory pressure, leading to respiratory discomfort and distress.<xref ref-type="bibr" rid="article-141285.r2">[2]</xref>&#x000a0;Failure to trigger can be seen in neuromuscular diseases such as ALS, where the patient&#x000a0;cannot generate enough negative pressure during inspiration to trigger the assisted breath.<xref ref-type="bibr" rid="article-141285.r27">[27]</xref></p>
      </sec>
      <sec id="article-141285.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Respiratory failure is a life-threatening condition responsible for around 30% of in-hospital mortality. The definitive treatment for respiratory failure is mechanical intubation and ventilation. However, this process is associated with significant morbidity and mortality.<xref ref-type="bibr" rid="article-141285.r28">[28]</xref>&#x000a0;These include complications with intubation, such as laryngospasm, bronchospasm, incorrect tube placement, aspiration, and hypotension, as well as complications from prolonged time on mechanical ventilation, including ventilator-induced lung injury, ventilator-associated pneumonia, and GI complications, including peptic ulcers and colonization of the GI tract by aerobic gram-negative bacteria. NPPV has been shown to reduce intubation in COPD, cardiogenic pulmonary edema, and pneumonia and reduce the need for reintubation in hypercapnic respiratory failure following extubation.&#x000a0;However, NPPV is a time-consuming procedure requiring high resource utilization and should only be performed under a clinician and support staff with proficiency in its use.</p>
        <p>
<bold>Clinical Pearls</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Start treatment as early as possible.</p>
          </list-item>
          <list-item>
            <p>When arterial pH is less than 7.35, and PaCO<sub>2</sub> is elevated, it indicates the presence of acute&#x000a0;or acute chronic hypercapnia respiratory failure, which requires admission to the ICU.</p>
          </list-item>
          <list-item>
            <p>The first goal is to correct arterial pH in acute or chronic hypercapnia respiratory failure.</p>
          </list-item>
          <list-item>
            <p>High-intensity&#x000a0;pressure support is indicated in chronic hypercapnic respiratory failure with arterial PaCO<sub>2</sub> of&#x000a0;more than 51 mmHg. It should be targeted to&#x000a0;correct CO<sub>2</sub> toward normal or at least reduced by 20% from initial levels.</p>
          </list-item>
          <list-item>
            <p>When OSA is suspected, the EPAP&#x000a0; should be adjusted empirically (use the 10% rule of actual body weight) if no PAP titration was performed.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-141285.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>NPPV is initiated at the physician level but requires the cooperation of an interprofessional team to ensure its success. While the&#x000a0;physician performs the initial settings and titration, a team usually does subsequent patient monitoring, including nurses with critical care training and respiratory therapists. The patient's mental status and vital signs must be continuously monitored, and any abnormalities must be recognized and reported to the physician expediently. Should hypotension develop,&#x000a0;intravenous access should be secured before initiation of NPPV. The patient needs frequent arterial/venous blood gas draws during titration of NPPV. During transfers of care, it is&#x000a0;vital to communicate the patient&#x02019;s prior NPPV settings and changes to ensure optimal adjustment and effectiveness of NPPV.</p>
      </sec>
      <sec id="article-141285.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=141285&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=141285">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/141285/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=141285">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-141285.s13">
        <title>References</title>
        <ref id="article-141285.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slutsky</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>History of Mechanical Ventilation. From Vesalius to Ventilator-induced Lung Injury.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2015</year>
            <month>May</month>
            <day>15</day>
            <volume>191</volume>
            <issue>10</issue>
            <fpage>1106</fpage>
            <page-range>1106-15</page-range>
            <pub-id pub-id-type="pmid">25844759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive ventilation.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>163</volume>
            <issue>2</issue>
            <fpage>540</fpage>
            <page-range>540-77</page-range>
            <pub-id pub-id-type="pmid">11179136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meduri</surname>
                <given-names>GU</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leeper</surname>
                <given-names>KV</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive positive pressure ventilation in status asthmaticus.</article-title>
            <source>Chest</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>767</fpage>
            <page-range>767-74</page-range>
            <pub-id pub-id-type="pmid">8797425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LASSEN</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency.</article-title>
            <source>Lancet</source>
            <year>1953</year>
            <month>Jan</month>
            <day>03</day>
            <volume>1</volume>
            <issue>6749</issue>
            <fpage>37</fpage>
            <page-range>37-41</page-range>
            <pub-id pub-id-type="pmid">13011944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Brochard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Nava</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Navalesi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guntupalli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jaber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Keenan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mancebo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Raoof</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.</article-title>
            <source>Eur Respir J</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">28860265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gay</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>RL</given-names>
              </name>
              <collab>ONMAP Technical Expert Panel</collab>
            </person-group>
            <article-title>Executive Summary: Optimal NIV Medicare Access Promotion: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society.</article-title>
            <source>Chest</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>160</volume>
            <issue>5</issue>
            <fpage>1808</fpage>
            <page-range>1808-1821</page-range>
            <pub-id pub-id-type="pmid">34339685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daoud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haider</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sankari</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive Ventilation and Spinal Cord Injury.</article-title>
            <source>Sleep Med Clin</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-470</page-range>
            <pub-id pub-id-type="pmid">33131657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r8">
          <label>8</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Neupane</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jamil</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <chapter-title>Physiology, Transpulmonary Pressure</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">32644430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Pressure-volume curves of the respiratory system.</article-title>
            <source>Respir Care</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <page-range>78-98; discussion 98-9</page-range>
            <pub-id pub-id-type="pmid">15636647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perlman</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Lederer</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Micromechanics of alveolar edema.</article-title>
            <source>Am J Respir Cell Mol Biol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-9</page-range>
            <pub-id pub-id-type="pmid">20118224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Inspiratory work with and without continuous positive airway pressure in patients with acute respiratory failure.</article-title>
            <source>Anesthesiology</source>
            <year>1985</year>
            <month>Dec</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>598</fpage>
            <page-range>598-607</page-range>
            <pub-id pub-id-type="pmid">3904528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kallet</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>The physiologic effects of noninvasive ventilation.</article-title>
            <source>Respir Care</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-15</page-range>
            <pub-id pub-id-type="pmid">19111110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <collab>British Thoracic Society Standards of Care Committee</collab>
            <article-title>Non-invasive ventilation in acute respiratory failure.</article-title>
            <source>Thorax</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>192</fpage>
            <page-range>192-211</page-range>
            <pub-id pub-id-type="pmid">11867822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000f6;nhofer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sortor-Leger</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Equipment needs for noninvasive mechanical ventilation.</article-title>
            <source>Eur Respir J</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>1029</fpage>
            <page-range>1029-36</page-range>
            <pub-id pub-id-type="pmid">12412700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000f6;nhofer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kuhlen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Westhoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berndt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sitter</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice guideline: non-invasive mechanical ventilation as treatment of acute respiratory failure.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>105</volume>
            <issue>24</issue>
            <fpage>424</fpage>
            <page-range>424-33</page-range>
            <pub-id pub-id-type="pmid">19626185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kushida</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Chediak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Gozal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Iber</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parthasarathy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quan</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Rowley</surname>
                <given-names>JA</given-names>
              </name>
              <collab>Positive Airway Pressure Titration Task Force</collab>
              <collab>American Academy of Sleep Medicine</collab>
            </person-group>
            <article-title>Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea.</article-title>
            <source>J Clin Sleep Med</source>
            <year>2008</year>
            <month>Apr</month>
            <day>15</day>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-71</page-range>
            <pub-id pub-id-type="pmid">18468315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wolfe</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Kalhan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>1091</fpage>
            <page-range>1091-1098</page-range>
            <pub-id pub-id-type="pmid">31185181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive positive pressure ventilation in acute respiratory failure due to COPD vs other causes: effectiveness and predictors of failure in a respiratory ICU in North India.</article-title>
            <source>Int J Chron Obstruct Pulmon Dis</source>
            <year>2008</year>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>737</fpage>
            <page-range>737-43</page-range>
            <pub-id pub-id-type="pmid">19281088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Grote</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ploch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stammnitz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Podszus</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Intrathoracic pressure changes and cardiovascular effects induced by nCPAP and nBiPAP in sleep apnoea patients.</article-title>
            <source>J Sleep Res</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>S1</issue>
            <fpage>125</fpage>
            <page-range>125-129</page-range>
            <pub-id pub-id-type="pmid">10607188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Philip-Jo&#x000eb;t</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Paganelli</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Dutau</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Saadjian</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure.</article-title>
            <source>Respiration</source>
            <year>1999</year>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-43</page-range>
            <pub-id pub-id-type="pmid">10202317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>K&#x000f6;hnlein</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Windisch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>K&#x000f6;hler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Drabik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Geiseler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hartl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karg</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Laier-Groeneveld</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nava</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;nhofer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schucher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wegscheider</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cri&#x000e9;e</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Welte</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial.</article-title>
            <source>Lancet Respir Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>9</issue>
            <fpage>698</fpage>
            <page-range>698-705</page-range>
            <pub-id pub-id-type="pmid">25066329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osadnik</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Tee</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Carson-Chahhoud</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Picot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wedzicha</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jul</month>
            <day>13</day>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>CD004104</fpage>
            <pub-id pub-id-type="pmid">28702957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dreher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Storre</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Schmoor</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Windisch</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial.</article-title>
            <source>Thorax</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-8</page-range>
            <pub-id pub-id-type="pmid">20388753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masa</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>P&#x000e9;pin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Borel</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mokhlesi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Quiroga</surname>
                <given-names>M&#x000c1;</given-names>
              </name>
            </person-group>
            <article-title>Obesity hypoventilation syndrome.</article-title>
            <source>Eur Respir Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <day>31</day>
            <volume>28</volume>
            <issue>151</issue>
            <pub-id pub-id-type="pmid">30872398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thein</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Niazi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sahal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pneumomediastinum in patients with SARS-CoV-2 treated with non-invasive ventilation.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Mar</month>
            <day>23</day>
            <volume>14</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33758053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kabi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaeley</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roul</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>COVID-19-Associated Pneumomediastinum and Pneumothorax: A Case Series.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>9</issue>
            <fpage>e17715</fpage>
            <pub-id pub-id-type="pmid">34650889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicholson</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Siddique</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sufit</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ajroud-Driss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wolfe</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Respiratory Pattern and Tidal Volumes Differ for Pressure Support and Volume-assured Pressure Support in Amyotrophic Lateral Sclerosis.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>7</issue>
            <fpage>1139</fpage>
            <page-range>1139-1146</page-range>
            <pub-id pub-id-type="pmid">28410001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-141285.r28">
          <label>28</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Haribhai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahboobi</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <chapter-title>Ventilator Complications</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>9</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">32809370</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
